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In Brief
In general, the transformation of cells in-
volves multiple genetic lesions that un-
dermine control of both cell death and
cell proliferation. Here, Oeckinghaus
et al. describe kB-Ras proteins negatively
regulating both the NF-kB and Ral path-
ways. kB-Ras proteins thus possess a
unique dual-tumor suppressor function
by simultaneously controlling inflamma-
tion/cell death and proliferation. Different
human tumors demonstrate reduced
levels of kB-Ras, which provides a growth
advantage to the respective cancer cells.
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The transformation of cells generally involves multi-
ple genetic lesions that undermine control of both
cell death and proliferation. We now report that
kB-Ras proteins act as regulators of NF-kB and Ral
pathways, which control inflammation/cell death
and proliferation, respectively. Cells lacking kB-Ras
therefore not only show increased NF-kB activity,
which results in increased expression of inflamma-
tory mediators, but also exhibit elevated Ral activity,
which leads to enhanced anchorage-independent
proliferation (AIP). kB-Ras deficiency consequently
leads to significantly increased tumor growth that
can be dampened by inhibiting either Ral or NF-kB
pathways, revealing the unique tumor-suppressive
potential of kB-Ras proteins. Remarkably, numerous
human tumors show reduced levels of kB-Ras, and
increasing the level of kB-Ras in these tumor cells im-
pairs their ability to undergo AIP, thereby implicating
kB-Ras proteins in human disease.INTRODUCTION
Transformation of cells is a multistep process that culminates in
dysregulated proliferation and survival. The classical Ras guano-
sine triphosphate hydrolases (GTPases), H-Ras, K-Ras, and
N-Ras, are critical regulators of proliferation, and it is thus not
surprising that they represent the most frequently mutated hu-
man oncogenes (Cox and Der, 2010). GTPases of the Ras super-
family function as cellular switches by cycling through guanine
nucleotide-dependent conformational transitions (Wennerberg
et al., 2005). Signal transduction through interaction with their
effectors requires GTP binding, which is promoted by guanine
nucleotide exchange factors (GEFs). The reverse process is
catalyzed by GTPase-activating proteins (GAPs), which enhance
the intrinsic GTP hydrolysis activity of GTPases and thus accel-
erate transition to the guanosine diphosphate (GDP)-bound OFF
state (Bos et al., 2007; Cherfils and Zeghouf, 2013; Colicelli,Cell Re2004). In over 30% of human tumors, classical Ras proteins
are mutated at positions G12, G13, and Q61, which inhibits
GTP hydrolysis and locks the Ras proteins in a constitutively
active, GTP-bound form (Karnoub and Weinberg, 2008; Young
et al., 2009). Thesemutated Ras proteins trigger aberrant activa-
tion of several effector pathways such as PI3 (phosphatidylinosi-
tol-3) kinase, Raf kinase and Ral GTPases that collaboratively
contribute to tumorigenesis (Karnoub and Weinberg, 2008;
Young et al., 2009).
The Ral GTPases, RalA and RalB, are members of the Ras su-
perfamily and have been shown to regulate diverse cellular pro-
cesses, such as vesicular transport, cytoskeletal organization,
and cell proliferation (Feig, 2003). Ral GTPases can be activated
through several GEFs, many of which are bona fide Ras effectors
(de Bruyn et al., 2000; Rebhun et al., 2000; Shao and Andres,
2000; Wolthuis and Bos, 1999). More recent studies have further
suggested that inactivation of the two described heterodimeric
Ral-GAP complexes, Ral-GAP1 and Ral-GAP2, is sufficient to
elicit Ral activation (Chen et al., 2011; Leto et al., 2013; Saito
et al., 2013). The Ral-GAP complexes contain the regulatory
subunit Ral-GAPb and the catalytic subunits Ral-GAPa1 or Ral-
GAPa2, respectively (Gridley et al., 2006; Shirakawa et al.,
2009). Association of the a subunits with Ral-GAPb has been
shown to be essential for Ral-GAP activity, and both Ral-GAP
complexes have activity toward RalA and RalB, in vitro (Chen
et al., 2011; Gridley et al., 2006; Shirakawa et al., 2009). In recent
years, Ral GTPases have emerged as critical effectors of Ras-
driven tumorigenesis: chronic Ral activity has been detected in
a variety of tumor types and genetic ablation of RalA and RalB
blocks K-Ras-driven tumor formation in mice (Peschard et al.,
2012). In this context, Ral GTPases are key regulators of
anchorage-independent proliferation (AIP), which is a hallmark
of cancer cells as it allows tumors to expand and spread (Bode-
mann and White, 2008; Chien and White, 2003; Lim et al., 2005,
2006;Martin et al., 2011;Peschard et al., 2012;Smithet al., 2007).
Maintenance of cellular homeostasis, however, depends not
only on control of proliferative pathways but also of cell death.
In addition, recent studies have revealed a strong connection be-
tween inflammation and cancer development (Ben-Neriah and
Karin, 2011; Karin, 2006). A major regulator of both of these pro-
cesses is the transcription factor NF-kB, which can induce theports 8, 1793–1807, September 25, 2014 ª2014 The Authors 1793
Figure 1. Genetic Ablation of kB-Ras1 and
kB-Ras2 Leads to Perinatal Lethality
(A) Newborn kB-Ras1/2+/ (2het), kB-Ras1/2+/+
(2WT), and kB-Ras1/2/ (DKO) pups 1 hr after
birth.
(B) Lung sections of kB-Ras DKO and control lit-
termates were prepared on gestational day E18.5
and right after birth (P0) and stained with hema-
toxylin and eosin.
(C) Lung sections were prepared and stained for
PCNA. PCNA-positive cells were counted per field
of view. Data are represented as mean ± SD (Stu-
dent’s t test: p = 0.014; n = 4).
(D) Quantitative PCR (qPCR) analysis of surfactant
protein mRNA levels in lungs from newborn kB-Ras
DKO and control littermates (kB-Ras1/2+/+).
Data are represented as mean ± SD (Student’s t
test; n = 12).
See also Figure S1.expression of proinflammatory cytokines, chemokines, adhe-
sion molecules, as well as prosurvival, antiapoptotic molecules
(Hayden and Ghosh, 2012). NF-kB activity is regulated through
cytoplasmic sequestration by the inhibitory IkB proteins (Hayden
and Ghosh, 2008). Degradation of IkB proteins is triggered upon
phosphorylation by the IKK complex and releases the bound NF-
kB, which translocates to the nucleus and induces transcription.
The two major IkB proteins, IkBa and IkBb, exhibit distinct regu-
lation and function. IkBa is degraded rapidly and then resynthe-
sized, allowing it to suppress activated nuclear NF-kB. Degrada-
tion of IkBb is slower andmore persistent (Hoffmann et al., 2002;
Tam and Sen, 2001; Thompson et al., 1995; Tran et al., 1997).
Importantly, newly synthesized IkBb, characterized by its
hypophosphorylated state, acts in the nucleus at promoters/
enhancers of particular inflammatory genes to ensure their
persistent expression (Rao et al., 2010; Scheibel et al., 2010).
Therefore, cells lacking IkBb show reduced expression of critical
proinflammatory genes such as tumor necrosis factor a (TNF-a)
and a consequent reduction in inflammation in animal models of
septic shock or collagen-induced arthritis (Rao et al., 2010).
In an effort to understand the unique biological properties of
IkBb, we identified a class of Ras-like proteins that we named
kB-Ras1 (NKIRAS1) and kB-Ras2 (NKIRAS2) as IkBb-interacting
proteins (Fenwick et al., 2000). Whereas these evolutionarily
conserved proteins display a high degree of homology with
Ras GTPases, they differ in two key respects. First, the kB-Ras
proteins have amino acids at positions 12, 13, and 61 that predict
a constitutively GTP-bound state. Second, they lack sequences
at the C terminus necessary for farnesylation and membrane
attachment. Consequently, kB-Ras proteins are not generally
membrane associated but rather display cytoplasmic and nu-
clear distribution (A.O. and S.G., unpublished data; Tago et al.,1794 Cell Reports 8, 1793–1807, September 25, 2014 ª2014 The Authors2010). Whereas overexpression experi-
ments demonstrated that kB-Ras could
inhibit NF-kB activation (Chen et al.,
2003, 2004; Fenwick et al., 2000; Tago
et al., 2010), studies on the endogenous
proteins were lacking.To better understand the biological role of kB-Ras proteins, we
created mice lacking both kB-Ras isoforms. These mice reveal
an unexpected role for kB-Ras proteins in lung development
and confirm kB-Ras proteins as critical regulators of IkBb-
dependent NF-kB activation and consequent inflammatory
responses in vivo. We also report that kB-Ras proteins are asso-
ciated with Ral-GAP proteins and are essential for their GAP
activity toward the Ral GTPases. kB-Ras-deficient cells demon-
strate a striking increase in Ral-GTP levels and consequently AIP
in vitro and tumor growth in vivo. Furthermore, decreased kB-
Ras expression, detected in several human cancers, provides
a growth advantage to tumor cells, strongly implicating kB-Ras
proteins as tumor suppressors.
RESULTS
Deficiency of kB-Ras1 and kB-Ras2 Causes Perinatal
Lethality
kB-Ras1 (1SKO) and kB-Ras2 (2SKO)-deficient mice were
generated using conventional strategies (Figures S1A–S1D).
Both mouse strains were viable without obvious phenotypes
(Figure S1E). However, kB-Ras1/kB-Ras2 double knockout
(DKO) led to perinatal lethality. DKO pups died within hours after
birth, exhibiting a hunched posture and central cyanosis, sug-
gesting a ventilatory defect (Figures 1A and S1F).
Whereas histopathological examination of all other major
organs revealed no gross defects, sections of the lungs of kB-
Ras DKO pups displayed hypercellularity and reduced alveolar
inflation in comparison to littermate controls (Figure 1B). Quanti-
fication of immunohistochemical proliferating cell nuclear anti-
gen (PCNA) staining confirmed an increase in proliferating cells
in lungs from newborn DKOmice (Figure 1C). Insufficient alveolar
inflation causing respiratory failure is often linked to disturbed
pulmonary surfactant production. The surfactant proteins
SP-A, SP-B, SP-C, and SP-D are critical for surface mainte-
nance, lung inflation at birth, and general lung function (Frerking
et al., 2001; Weaver and Conkright, 2001). We found that mRNA
levels for all four surfactant proteins were significantly reduced in
lungs of late-stage DKO embryos (Figure S1G) and newborn
DKO offspring (Figure 1D), likely explaining the observed reduc-
tion in lung inflation. These findings suggest that lung hypercel-
lularity and inadequate alveolar inflation lead to perinatal lethality
of kB-Ras DKO mice and thereby reveal an unexpected role for
kB-Ras proteins in lung development.
kB-Ras2 Knockout Mice Show Enhanced
IkBb-Dependent Inflammatory Responses
We first analyzed the effects of complete kB-Ras deficiency on
NF-kB signaling in mouse embryonic fibroblasts (MEFs). We
found that IkBb, but not IkBa, degradation was enhanced (Fig-
ure 2A). The analysis of IkBb knockouts had shown that IkBb
regulated only a subset of NF-kB-dependent genes, including
TNF-a, but not other well-characterized NF-kB target genes
such as interleukin (IL)-6 (Rao et al., 2010). Interestingly, expres-
sion of TNF-a, but not of IL-6, was increased in DKO MEFs in
response to lipopolysaccharide (LPS) when compared to wild-
type cells (Figure 2B). The lethality of DKOmice prevented direct
investigation of dysregulation of the inflammatory response in
mice lacking both kB-Ras isoforms. However, we found that, in
macrophages, kB-Ras2 was expressed at a significantly higher
level than kB-Ras1 (Figure 2C). Thus, we investigated whether
kB-Ras2-deficient macrophages (2SKO) might behave like kB-
Ras1/kB-Ras2 DKOs and demonstrate enhanced NF-kB-
dependent transcription.
Consistent with the experiments carried out in DKO MEFs, we
found that 2SKOmacrophages showed enhanced expression of
TNF-a, but not IL-6 (Figure 2D). A miniarray containing 92 NF-kB
target genes confirmed that absence of kB-Ras2 affects only a
subset of NF-kB target genes (Figure S2A). Macrophages that
also lacked IkBb, in addition to kB-Ras2, failed to show
increased levels of TNF-a (Figures 2D, S2B, and S2C), thereby
establishing kB-Ras2 as a regulator of IkBb-dependent NF-kB
activity. In agreement with these findings, kB-Ras2-deficient
mice were significantly more susceptible in a LPS-induced
septic shock model where sensitivity largely depends on the
NF-kB-induced production of proinflammatory cytokines by
macrophages (Figure 2E). As predicted by the results on isolated
macrophages, the enhanced septic shock lethality of kB-Ras2
knockouts was nearly abolished when IkBb was also deleted
from these mice (Figure 2F). These results suggest that kB-Ras
proteins indeed regulate NF-kB activity in primary cells in an
IkBb-dependent fashion and that kB-Ras function is required
for regulating inflammation in vivo.
We next asked whether increased cytokine production might
play a role in the perinatal lethality of DKO pups as TNF-a can
act as a potent inhibitor of surfactant protein expression (Bach-
urski et al., 1995; Pryhuber et al., 1996; Wispe´ et al., 1990). Anal-
ysis of lung tissues of newborn kB-Ras DKO mice revealed
enhanced levels of TNF-a (Figure 2G). Importantly, concomitant
deletion of TNF receptor 1 (TNFR1; Tnfrsf1a) could partiallyCell Rerescue perinatal lethality of DKO mice with about 15% of the ex-
pected number of pups surviving (Figure S2D). The triple-
knockout mice (Nkiras1/Nkiras2/Tnfr1/) were runted and
mostly obtained when litter size was small, implying that sibling
competition might decrease the survival of these weaker mice.
Nevertheless, the surviving triple knockouts were viable (Fig-
ure 2H). The rescue from lethality through TNFR1 ablation
strongly suggests that the completely penetrant lethality of kB-
Ras DKO mice are due to increased levels of TNF-a.
kB-Ras Proteins Interact with Ral-GAP Complexes
To identify potential kB-Ras-interacting proteins, we performed
tandem-affinity purification (TAP) with tagged kB-Ras2, fol-
lowed by mass spectrometry (Figure 3A). Interestingly, we de-
tected subunits of the Ral-GAP complexes in our purified
samples (Figure 3B). Confirming these results, we detected
binding of endogenous Ral-GAP to TAP-tagged kB-Ras2, as
well as association of endogenous kB-Ras proteins with both
Ral-GAP complexes by immunoblot analysis (Figures 3C and
3D). Furthermore, gel-filtration experiments demonstrated that
a large fraction of endogenous kB-Ras forms a high-molecu-
lar-weight complex with Ral-GAP under resting cellular condi-
tions (Figure 3E).
To characterize the architecture of the kB-Ras:Ral-GAP com-
plexes, we overexpressed kB-Ras1 or kB-Ras2 and different
combinations and deletions of Ral-GAP subunits in human em-
bryonic kidney 293 (HEK293) cells, which possess very low
levels of endogenous Ral-GAP (A.O. and S.G., unpublished
data; Leto et al., 2013). We found that both kB-Ras1 and
kB-Ras2 interacted with the catalytic subunits Ral-GAPa1 or
Ral-GAPa2 and that this interaction was independent of coex-
pression of the regulatory subunit, Ral-GAPb (Figures 3F and
3G). In contrast, coprecipitation of Ral-GAPb with kB-Ras1 or
kB-Ras2 required the presence of Ral-GAPa1 or Ral-GAPa2,
demonstrating that kB-Ras proteins bind to the Ral-GAPa cata-
lytic subunits (Figures 3H and 3I). Progressive deletions from the
N terminus or C terminus of Ral-GAPa revealed that kB-Ras pro-
teins did not bind to the C-terminal GAP domain; instead, the
kB-Ras-binding domain was located within the N-terminal 150
amino acids, a region of undefined structure and function, which
is highly homologous between Ral-GAPa1 and Ral-GAPa2 (Fig-
ures S3A–S3D). In agreement with these findings, coexpression
of kB-Ras did not compete with Ral for binding to Ral-GAP,
which occurs through the C-terminal GAP domain (Figure S3E).
Next, we introduced mutations in kB-Ras2 that force a GDP-
bound state (kB-Ras2 T18D and D61A; Tago et al., 2010). Bind-
ing of these kB-Ras2 mutants to Ral-GAPa2 was significantly
reduced compared to wild-type kB-Ras, demonstrating that
constitutive GTP binding is required for association of kB-Ras
with Ral-GAP (Figure 3J). Interestingly, the kB-Ras T18N mutant
has previously been shown to retain the inhibitory effect of
kB-Ras on NF-kB activity (Tago et al., 2010), suggesting that
regulation of Ral-GAP and NF-kB activity are independent and
differentially regulated functions of kB-Ras proteins. Together,
these results reveal a remarkable role for GTP-bound kB-Ras
proteins as constitutive cofactors of Ral-GAPs, with the interac-
tion occurring through a previously uncharacterized GTPase-
binding region in the Ral-GAPa subunits.ports 8, 1793–1807, September 25, 2014 ª2014 The Authors 1795
Figure 2. kB-Ras Deficiency Leads to Upregulation of IkBb-Dependent NF-kB Activity
(A) Wild-type and DKO primary embryonic fibroblasts (MEFs) were stimulated with LPS, and IkB degradation was analyzed by immunoblot.
(B) Wild-type and DKOMEFs were stimulated with LPS and mRNA levels of TNF-a, and IL-6 were analyzed by qPCR. Data are represented as mean ± SD (n = 3).
(C) Bone-marrow-derived macrophages (BMDMs) from wild-type mice were analyzed for kB-Ras1 and kB-Ras2 mRNA levels by qPCR. Data are represented as
mean ± SD (n = 3).
(D) BMDMs of the indicated genotypes were stimulated with different doses of LPS. TNF-a and IL-6 mRNA levels were analyzed by ELISA. Data are represented
as mean ± SD (n = 3).
(E) A total of 20 kB-Ras2-deficient mice and 20 control wild-type littermates were intraperitoneally injected with LPS (18 mg LPS/g body weight) in three inde-
pendent experiments and survival was monitored. For statistical analysis, a Mantel-Cox test was performed.
(F) Mice with the indicated genotypes were injected with LPS (18 mg LPS/g body weight) andmonitored for survival. For statistical analysis, a Mantel-Cox test was
performed (n = 5).
(G) TNF-a mRNA levels in lungs of newborn DKO mice were analyzed by qPCR. Data are represented as mean ± SEM (Student’s t test; n = 11).
(H) kB-Ras1/kB-Ras2/TNFR/ and kB-Ras1/kB-Ras2+/TNFR/ mice at the age of 21 days.
See also Figure S2.
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kB-Ras Proteins Regulate the Ral Pathway by Activating
the Ral-GAP Complex
Based on the identification of the Ral-GAP-kB-Ras interaction,
we decided to investigate a possible role of kB-Ras proteins in
the Ras/Ral-signaling network. To detect Ral activity in cells,
we used immobilized, recombinant glutathione S-transferase
(GST)-tagged Ral-binding domain of the Ral effector Sec5
(amino acids [aas] 1–99) to specifically pull down GTP-loaded
forms of Ral GTPases from cell lysates. We found that the levels
of GTP-bound RalA and RalB were dramatically increased in kB-
Ras DKO cells, under resting conditions and in response to
epidermal growth factor (EGF) (Figures 4A, 4B, and S4A).
Absence of kB-Ras1 or kB-Ras2 alone did not affect Ral-GTP
levels, and increased levels of Ral-GTP in the DKO cells could
be reversed by reintroduction of kB-Ras1 or kB-Ras2 (Figures
4A–4C, S4B, and S4C). This demonstrates that both kB-Ras pro-
teins are important in Ral signaling and that, in cell types that
express both kB-Ras isoforms, absence of both is required to in-
crease Ral-GTP levels. Ras-GTP levels were unaltered in
kB-Ras-deficient cells, demonstrating that Ral deregulation in
kB-Ras DKO MEFs does not occur through an effect on Ras-
induced Ral-GEF activation (Figure 4D). Furthermore, the Raf/
mitogen-activated protein kinase (MAPK) and phosphatidylino-
sitol 3-kinase (PI3K)/Akt-signaling pathways were unaffected in
kB-Ras DKO cells as assayed by phosphorylation of Erk and
Akt, revealing that kB-Ras deficiency specifically affects Ral
signaling downstream of Ras (Figures 4A and 4B).
The fact that kB-Ras proteins interacted with Ral-GAP com-
plexes and that Ral-GTP levels were upregulated in kB-Ras
DKO cells whereas Ras-GTP levels were unaltered suggested
that kB-Ras proteins might positively regulate the activity of
Ral-GAP complexes. Absence of kB-Ras proteins would conse-
quently lead to a reduction of GAP activity and increased levels
of active Ral. Furthermore, as levels of Ral-GTPwere augmented
in unstimulated kB-Ras DKO cells, we hypothesized that consti-
tutive Ral-GAP activity might be required to prevent aberrant Ral
signaling under resting conditions. Indeed, abrogation of Ral-
GAP activity through stable knockdown of Ral-GAPb resulted
in increased Ral-GTP levels comparable to those seen in kB-Ras
DKO MEFs (Figures 4E and S4D). Next, we wished to directly
demonstrate that kB-Ras regulates Ral signaling through an ef-
fect on Ral-GAP. Because expression and heterodimer forma-
tion of Ral-GAP subunits were unaltered in kB-Ras DKO cells
(Figures S4E–S4G), we tested whether binding of kB-Ras to
Ral-GAP could alter the function of the complex in cells. As
expected, overexpression of Ral-GAP complex subunits
decreased Ral-GTP levels in HEK293 cells. Coexpression of
kB-Ras, however, enhanced Ral-GAP activity and consequently
further lowered Ral-GTP levels, demonstrating that kB-Ras as-
sociation boosts GAP activity (Figure 5A). Next, we generated
a fast-exchanging RalA mutant F39L, which is activated largely
independently of GEFs but is still responsive to GAP function
and has previously been used to distinguish between GEF-
and GAP-dependent Ral-activating events (Chen et al., 2011).
We found that RalA F39L-GTP levels were much higher in kB-
Ras DKO cells than in wild-type cells, demonstrating that Ral-
GAP, but not Ral-GEF, activity is deregulated in the absence of
kB-Ras proteins (Figure 5B). In addition, we overexpressed aCell Redominant-negative RalA mutant, RalA S28N, that had previously
been demonstrated to inhibit Ral-GEF-dependent activation of
Ral GTPases (Bodempudi et al., 2009; Urano et al., 1996; Vigil
et al., 2010). Expression of RalA S28N did not alter Ral-GTP
levels in kB-Ras DKO MEFs (Figure 5C), confirming that kB-
Ras regulates Ral activity through a GEF-independent mecha-
nism. Together, these results reveal that kB-Ras proteins are
essential for Ral-GAP activity and consequently for controlling
Ral signaling in cells.
kB-Ras Proteins Regulate AIP by Affecting the
Ral Pathway
Ral GTPases have been implicated in the regulation of various
cellular processes, including cytoskeletal rearrangements, pro-
tein trafficking, and autophagy. Furthermore, RalB activity has
been demonstrated to help mounting immune responses to viral
infections through promoting production of IRF3 target genes
such as interferon b (IFNb) and ISG56/IFIT1(Chien et al., 2006).
Importantly, Ral GTPases regulate cell survival and proliferation
under anchorage-independent growth conditions in an onco-
genic context (Bodemann and White, 2008; Feig, 2003). We
therefore next examined the proliferation characteristics of kB-
Ras-deficient cells. Comparing the growth of primary as well
as SV40-immortalized wild-type, kB-Ras1 single-knockout
(SKO), kB-Ras2 SKO, and the kB-Ras1/kB-Ras2 DKOMEFs un-
der adherent conditions failed to show any significant difference
(Figure 5D; data not shown). However, when we performed col-
ony formation assays under anchorage-independent conditions,
we observed that absence of both kB-Ras proteins greatly
enhanced AIP of immortalized MEFs (Figure 5E). In agreement
with the previously demonstrated redundancy between kB-Ras
proteins in Ral regulation in MEFs, re-expression of kB-Ras2 in
DKO MEFs to a level equivalent to the sum of total endogenous
kB-Ras1 and kB-Ras2 reduced colony formation to that of wild-
type MEFs (Figure 5E).
Several earlier studies had suggested that Ral activation does
not drive transformed growth in rodent fibroblasts, as overex-
pression of GTP-locked Ral did not cause potent transformation
(Collette et al., 2004; Hamad et al., 2002). Thus, we wished to
confirm that activation of Ral GTPases in our immortalized
MEFs indeed contributes to transformed growth. We examined
MEFs in which Ral activation was triggered by stable knockdown
of Ral-GAPb, which—like kB-Ras deficiency—specifically af-
fects the Ral, but not the Raf and PI3K pathways. We found
that Ral-GAP depletion resulted in a significant increase in AIP,
confirming the importance of Ral-GAP/Ral activity for this pro-
cess in our system (Figure 5F). To test whether increased Ral ac-
tivity was responsible for the increased AIP in kB-Ras DKOs, we
next blocked activity of both Ral GTPases by stable overexpres-
sion of the Ral-binding domain of Ral-BP1 (RBD-RBP1), which
acts as a Ral superrepressor (Chien and White, 2003). Inhibition
of Ral GTPases by RBD-RBP1 diminished AIP of kB-Ras DKO
cells, demonstrating that kB-Ras proteins can counteract AIP
through their effect on Ral signaling (Figure 5G).
We also analyzed whether kB-Ras proteins affect other Ral-
dependent processes. We found that autophagy was enhanced
in kB-Ras DKOMEFs, which could be counteracted by knocking
down RalB, thereby demonstrating Ral dependence (Figuresports 8, 1793–1807, September 25, 2014 ª2014 The Authors 1797
Figure 3. kB-Ras Proteins Interact with Ral-GAP Complexes
(A) C-terminal TAP-tag (CTAP)-kB-Ras2 was stably expressed in Raw 264.7 cells. Clone no. 2 was used for large-scale purifications and all further procedures.
(B) Interacting proteins of CTAP kB-Ras2 were identified by TAP proteomics. UniProtKB database (Musmuculus) analysis of the tandemmass spectrometry data
was performed using Protein Pilot and the Paragon algorithm.
(C) Resting WT MEFs were lysed and endogenous Ral-GAPa1 or Ral-GAPa2 immunoprecipitated. Association of kB-Ras and Ral-GAPb was analyzed by
immunoblotting.
(D) Raw cells stably expressing CTAP kB-Ras2 or TAP-Tag alone were lysed and CTAP kB-Ras2 precipitated with streptavidin agarose. Association of Ral-GAP
subunits was analyzed by immunoblotting.
(E) Raw 264.7 cell lysate was fractionated on a Superose 6 gel-filtration column. Elution fractions were analyzed by immunoblotting.
(legend continued on next page)
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Figure 4. kB-Ras Proteins Regulate Ral
Activity
(A) SV40-transformed WT, 1SKO, and DKO MEFs
were stimulated with EGF for the indicated times.
RalB-GTP levels were determined by pull-down
using immobilized recombinant GST-Sec5 RBD
(aas 1–99). Precipitates were analyzed by immu-
noblotting for RalB. GST-Sec5 levels were deter-
mined by Coomassie staining of PVDFmembrane.
p-Akt, phosphorylation of Akt at Thr308.
(B) Experiments were performed as in (A) and
analyzed by immunoblotting for RalA. pErk,
phospho-Erk.
(C) DKO MEFs were stably transduced with either
GFP or kB-Ras2. Cells were stimulated with EGF
and RalA-GTP levels determined as in (A).
(D) SV40-transformed WT, 1SKO, and DKO MEFs
were stimulated with EGF. After cell lysis, GTP-
bound Ras was pulled down by immobilized, re-
combinant GST-Raf1-RBD (Ras-binding domain)
and analyzed by immunoblotting for Ras.
(E) SV40-transformed MEFs were stably trans-
duced with two different small hairpin RNAs
(shRNAs) (sh#1 and sh#4) targeting Ral-GAPb.
RalA-GTP levels were determined by GST-Sec5
RBD pull-down and immunoblotting.
See also Figure S4.S5A and S5B). Furthermore, in agreement with our earlier find-
ings that kB-Ras2 is the major isoform in macrophages, we de-
tected increased Ral-GTP levels and enhanced production of
IFNb and ISG56/IFIT1 in kB-Ras2 SKOmacrophages upon poly-
inosinic-polycytidylic acid stimulation (Figures S5C and S5D).
This enhancement was Ral dependent as RalB knockdown
reduced ISG56/IFIT1 production (Figure S5E). Concordantly,
we also detected increased expression of ISG56/IFIT1 in Raw
cells, in which Ral activity was increased through Ral-GAPb
knockdown (Figure S5F). However, in contrast to kB-Ras defi-
ciency, Ral-GAP knockdown did not alter TNF-a production in
response to LPS stimulation, confirming that regulation of NF-
kB and Ral-GAP are independent functions of kB-Ras proteins
(Figure S5G).
kB-Ras Deficiency Promotes Ras-Driven Tumorigenesis
Chronic Ral activity is particularly relevant in cancers expressing
mutated classical Ras proteins, which have been shown to
trigger Ral activity through recruitment of Ral-GEFs as a critical
part of their tumorigenic program (Bodemann and White,
2008). Therefore, we tested whether kB-Ras proteins, through
their effect on Ral-GAP, might be able to curtail Ras-induced
Ral activation and counteract the tumorigenic potential of
mutated Ras oncogenes. We stably expressed an oncogenic
H-Ras mutant (H-Ras G12V) in DKO and Ral-GAPb knockdown
cells and the respective control cells (Figure S6A). As in immor-(F andG) HEK293 cells were transfected with the indicated plasmids. kB-Ras:Ral-
proteins with streptavidin agarose (Strep PD) and immunoblotting.
(H and I) HEK293 cells were transfectedwith the indicated plasmids. kB-Ras:Ral-G
(J) CTAP kB-Ras2 wild-type, T18N, and D61A were coexpressed with Flag Ral-
and (G).
See also Figure S3.
Cell Retalized MEFs, activation of Raf/MAPK and PI3K/Akt pathways
did not differ between Ras12V-expressing wild-type (WT) and
DKO cells as determined by immunoblot of Erk and Akt phos-
phorylation (Figure S6B). However, absence of either kB-Ras
or Ral-GAP led to further elevation of Ral-GTP levels when
compared to wild-type cells expressing H-Ras G12V, demon-
strating that abrogation of Ral-GAP activity further augments
oncogenic Ras-induced Ral activity (Figures 6A and S6C).
We next wanted to test whether absence of kB-Ras affects
oncogenic Ras-induced tumorigenesis. Foci formation assays
showed that absence of kB-Ras proteins promoted transforma-
tion of spontaneously immortalized MEFs (3T3 MEFs) through
oncogenic H-Ras G12V (Figure 6B). We then subcutaneously in-
jected Ras G12V expressing wild-type and kB-Ras DKO cells
into the flanks of scid-beige mice. Tumors devoid of kB-Ras pro-
teins showed significantly accelerated tumor growth as moni-
tored by tumor size and tumor weight (Figures 6C and S6D).
kB-Ras deficiency seemed to mainly affect proliferation,
whereas only mildly reducing apoptosis rates (Figures S6E and
S6F). Together, these findings reveal that kB-Ras proteins can
function as tumor suppressors in Ras-G12V-driven cancer,
counteracting oncogenic Ras-induced cellular transformation
and transformed growth in vivo.
In agreement with the assumption that enhanced Ral activity
can promote tumor growth in our system, knockdown of
Ral-GAP activity also led to increased tumor growth of RasGAPa2 or Ral-GAPa1 bindingwas determined by precipitation of CTAP kB-Ras
APb binding was determined by precipitation of CTAP kB-Ras as in (F) and (G).
GAPa2 in HEK293 cells. kB-Ras-associated proteins were analyzed as in (F)
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Figure 5. kB-Ras Proteins Inhibit Ral
Signaling through Activating Ral-GAPActiv-
ity and thus Counteract AIP
(A) HEK293 cells were transfected with the indi-
cated plasmids. Levels of RalB-GTP were exam-
ined by immunoblot after GST Sec5 pull-down.
(B) SV40-transformed WT or DKO MEFs were
stably transduced with the fast-cycling RalA F39L
mutant. Cells were stimulated with EGF and sub-
jected to GST-Sec5 pull-down.
(C) SV40-transformed DKO MEFs were stably
transduced with GFP or the dominant-negative
RalA S28Nmutant. Cells were stimulatedwith EGF
and subjected to GST-Sec5 RBD pull-down.
(D) BrDU incorporation of SV40-transformed WT,
1SKO, and DKO MEFs during proliferation.
(E) The ability of SV40-transformed WT, DKO
MEFs, and DKO MEFs, in which kB-Ras2 was
stably reintroduced, to grow under anchorage-in-
dependent conditions was tested in Matrigel col-
ony formation assays. Data are represented as
mean ± SD (n = 3; Student’s t test; p = 0.00022).
(F) SV40-transformed MEFs, in which Ral-GAPb
was stably knocked down (shRNA #4), and control
MEFs expressing a scrambled shRNA were
analyzed for their growth ability under anchorage-
independent conditions in Matrigel colony forma-
tion assays. Data are represented as mean ± SD
(n = 3; Student’s t test; p = 0.01013).
(G) The ability of SV40-transformed DKO MEFs
stably expressing GFP or RBP1-RBD (Ral-binding
domain of Ral-BP1; aas 393–499) to grow under
anchorage-independent conditions was tested in
Matrigel colony formation assays. Data are rep-
resented as mean ± SD (n = 3; Student’s t test; p =
0.032).
See also Figure S5.G12V-expressing cells in vivo (Figures 6D, S6G, and S6H). How-
ever, kB-Ras proteins can regulate both Ral- and NF-kB
signaling and increased NF-kB activity could also contribute to
enhanced tumor growth by direct effects on tumor cell survival
and through generation of a proinflammatory tumor environment
that further promotes proliferation (Barbie et al., 2009; Ben-
Neriah and Karin, 2011; Meylan et al., 2009). We therefore over-
expressed the Ral-superrepressor RBD-RBP1 or the IkB super-
repressor in Ras12V-transformed DKO MEFs and tested the
resulting effects on the increase of AIP in vitro and of Ras-driven
tumorigenesis in vivo (Figures 6E, 6F, and S6I). In agreement
with our previous results, expression of RBD-RBP1 strongly
decreased tumor growth of DKO MEFs. Expression of the IkB
superrepressor led to a milder but still significant reduction in
AIP and tumor growth. These results are in line with our finding
that kB-Ras proteins affect a limited, mostly proinflammatory
subset of NF-kB target genes. In agreement, we found that proin-
flammatory NF-kB target genes, such as TNF and KC (murine IL-
8 homolog) were significantly increased in kB-Ras DKO tumors
and were reduced by overexpression of the IkB superrepressor1800 Cell Reports 8, 1793–1807, September 25, 2014 ª2014 The Authors(Figures 6G, S7A, and S7B). Antiapop-
totic NF-kB target genes such as Bcl-XL
and the Bcl2 family member Bfl/A1 werealso upregulated in DKO tumors but more modestly, which likely
reflects a secondary effect of increased production of proinflam-
matory cytokines by DKO tumors (Figure S7A). Whereas TNF-a
was increased in kB-Ras DKO tumors only, known Ral-depen-
dent genes, such as MMP-1 (Smith et al., 2012) or CD24 (Smith
et al., 2006), were upregulated in both kB-Ras-deficient and Ral-
GAPb-depleted tumors (Figures 6G, 6H, and S7C). These results
confirm that kB-Ras and Ral-GAP function through a common
pathway and highlight that the regulation of NF-kB activity
through kB-Ras proteins is independent of their effect on Ral-
GAP/Ral activity. Importantly, these findings demonstrate that
kB-Ras effects on both proliferation and inflammation/cell death,
through the Ral and NF-kB pathways, respectively, contribute to
the tumor suppressor potential of these proteins.
kB-Ras Proteins Are Decreased in Human Tumors and
Affect the Tumorigenic Capacity of Cells Derived from
such Tumors
Data mining revealed that kB-Ras protein or mRNA levels are
reduced in a variety of human cancers, including breast cancer
(Finak et al., 2008; Karnoub et al., 2007), lung cancer (Garber
et al., 2001), glioblastoma (Murat et al., 2008; Sun et al., 2006),
glioma (Lin et al., 2012), renal cell carcinoma (Gerashchenko
et al., 2010), oral cancer (Jou et al., 2010), and esophageal
adenocarcinoma (Kim et al., 2010; Figures S7D and S7E).
Whereas the underlying mechanisms and resulting conse-
quences had not been addressed, these studies implied that
downregulation of kB-Ras might support tumorigenesis in
different oncogenic contexts. To further support this hypothesis,
we analyzed samples from patients with pancreatic ductal
adenocarcinoma, a highly aggressive cancer characterized by
the presence of mutated K-Ras in >90% of cases. We found
that mRNA levels for both kB-Ras proteins were significantly
decreased compared tomatched normal pancreas controls (Fig-
ure 7A). As kB-Ras levels had been reported to be low in lung
cancer, we next examined expression of kB-Ras in mutant or
wild-type K-Ras-expressing lung cancer cell lines. Remarkably,
we observed that the kB-Ras protein level was significantly lower
in the mutant K-Ras-expressing tumor cells (Figure 7B). These
mutant K-Ras-expressing cell lines have been demonstrated to
critically depend on Ral activity for survival (Barbie et al.,
2009), suggesting that downregulation of kB-Rasmight be espe-
cially advantageous for tumor growth under conditions of Ral
dependence. Raising kB-Ras levels by stable lentiviral transduc-
tion significantly diminished their potential to form colonies un-
der anchorage-independent growth conditions (Figures 7C and
7D and Figure S7F). Hence, lowering of kB-Ras levels represents
a tumorigenic advantage in human cancer cell lines, strongly
implicating kB-Ras-mediated regulation in human
tumorigenesis.
DISCUSSION
Tumorigenesis is a multifactorial process that leads to the loss of
normal controls on cell proliferation and cell death. A proinflam-
matory microenvironment can also potently support tumor
growth. The cellular pathways that trigger these biological pro-
cesses generally initiate from distinct regulatory molecules. We
have now found that kB-Ras proteins negatively regulate
the transcription factor NF-kB through IkBb and Ras/Ral
signaling through the Ral-GAP complexes. Hence, kB-Ras de-
ficiency leads to upregulation of both the NF-kB and Ral
pathways, which have been shown to control survival/inflamma-
tion as well as proliferation (AIP) in the context of tumorigenesis.
Consequently, kB-Rasdeficiency leads to significantly enhanced
AIP and tumorigenesis of grafted cells, as well as a concomitant
increase in inflammatory gene expression in tumors.
Due to the perinatal lethality of kB-Ras DKO mice, we tested
the tumorigenic potential of transformed kB-Ras-deficient cells
by grafting them subcutaneously. In this model, blocking the
NF-kB or Ral pathways leads to decreased tumor growth, impli-
cating both pathways in tumor formation. Inhibition of NF-kB
signaling had a more modest effect, but the tumors were grown
in immune-deficient mice, in which NF-kB-dependent inflam-
matory tumor-promoting effects are likely underemphasized.
Unfortunately, the perinatal lethality of kB-Ras-deficient mice
impeded analysis of the effect of complete kB-Ras deficiency
on tumorigenesis in a mouse model of cancer. Nevertheless,Cell Reour results establish that kB-Ras proteins function in two critical
pathways known to affect inflammation, cell proliferation, and
cell survival to counteract tumorigenesis; therefore, they appear
to possess a unique tumor-suppressive potential. Clinical rele-
vance of kB-Ras proteins is indicated through the observed
reduction of kB-Ras levels in several human cancers and the
fact that reduction of kB-Ras levels in cells derived from patients
promotes potent transformed growth.
The perinatal lethality of kB-Ras DKO mice was unexpected,
as knockouts of most other inhibitors of NF-kB lead to later post-
natal death. However, mice expressing catalytically inactive
CYLD also die soon after birth due to a lung phenotype, with
less inflated, hypercellular lungs (Trompouki et al., 2009).
Whereas the basis of the CYLD-related lung phenotype remains
uncharacterized, it is intriguing that abolishing function of
another negative regulator of the NF-kB pathway leads to a
phenotype similar to the kB-Ras knockouts. The rescue from
lethality observed upon deleting TNFR1 in kB-Ras DKO mice
clearly implicates TNF in the lung phenotype and early death,
possibly through reduction of surfactant protein production.
However, the low numbers and the runted phenotype of the
rescued mice suggest other pathways must be dysregulated
as well. Whether disturbance of Ral homeostasis contributes
to lethality remains to be investigated, though RalA, RalB, or
Ral-GAP complexes have not been linked to lung development
or function. Determining the exact reasons underlying the
lethality of kB-Ras DKO mice remains a topic for further
research.
In addition to their function in IkBb/NF-kB regulation, our
studies revealed interaction of kB-Ras proteins with Ral-GAP
complexes and a role for kB-Ras in the Ral pathway. Interest-
ingly, interaction of the Drosophila homologs of kB-Ras and
Ral-GAP (CG5521-PA) has recently been detected in a high-
throughput screen, suggesting evolutionary conservation of
the kB-Ras:Ral-GAP interaction (Guruharsha et al., 2011).
Whereas our studies demonstrate that kB-Ras proteins affect
the activity of Ral-GAP complexes in cells, the mechanism by
which kB-Ras binding alters Ral-GAP activity remains to be
determined. kB-Ras binding to the Ral-GAP complex does not
change its activity in vitro (A.O. and S.G., unpublished data),
suggesting that kB-Ras proteins regulate GAP activity in
conjunction with unknown cellular factors or affect subcellular
localization of Ral-GAP complexes. Regulation of GAP activity
by a constitutively associated, GTP-locked GTPase of the
same family represents a unique scenario. A similar situation
has only been suggested for the regulation of p190-B Rho-
GAP activity through direct interaction with the GTPase Rnd3
(Wennerberg et al., 2003). Like kB-Ras, Rnd3 is found GTP
bound under resting cellular conditions. However, it remains un-
clear whether Rnd proteins affect Rho GEF activity and how
Rnd proteins affect GAP activity, though recent studies have
suggested they might target p190-B to lipid rafts (Oinuma
et al., 2012). An analogous scenario could be imagined for the
regulation of Ral-GAP by kB-Ras; however, kB-Ras proteins
lack membrane-targeting sequences, and we do not observe
localization changes of ectopically expressed Ral-GAP subunits
in the absence of kB-Ras proteins (A.O. and S.G., unpublished
data). Elucidating the exact molecular mechanism by whichports 8, 1793–1807, September 25, 2014 ª2014 The Authors 1801
Figure 6. Enhanced Ral and NF-kB Signaling in kB-Ras-Deficient Cells Contribute to Their Tumorigenicity
(A) SV40/Ras12V-transformedWT and DKOMEFs were stimulated with EGF. RalA-GTP levels were determined by GST-Sec5 pull-down and immunoblotting for
RalA.
(B) 3T3-immortalized WT or DKO MEFs were retrovirally infected with either GFP or H-Ras G12V. Fourteen days after infection, foci formation was analyzed. A
representative picture of three independent experiments is given.
(C) SV40/RasG12V-transformed WT and DKO MEFs were subcutaneously injected into the flanks of scid-beige mice. Tumor volume ± SEM [mm3] was deter-
mined by caliper measurements (n = 9). In addition, representative pictures of subcutaneous tumors in mice (left panel) and resected tumors (right panel) are
shown.
(D) SV40/RasG12V-transformed MEFs, in which Ral-GAPb was stably knocked down (shRNA #4) and control MEFs expressing a scrambled shRNA were
subcutaneously injected into the flanks of scid-beige mice. Tumor volume (mm3) ± SEM is given (n = 11). In addition, representative pictures of resected tumors
are shown.
(legend continued on next page)
1802 Cell Reports 8, 1793–1807, September 25, 2014 ª2014 The Authors
kB-Ras proteins affect Ral-GAP activity and whether this inter-
action allows for stimulus-induced Ral activation under specific
conditions remains an important future objective and will require
generation of improved biochemical and genetic tools to study
Ral-GAP complexes.
In this study, we demonstrate that, in the absence of kB-Ras,
upregulation of the Ral pathway leads to increased AIP of immor-
talized MEFs. Although Ral GTPases have been linked to AIP of
human cancer cells by several independent studies, their
involvement in AIP regulation inmurine cells had been controver-
sial. This was largely due to earlier studies demonstrating that
ectopic expression of activated Ral mutants, or Ras mutants
that specifically trigger Ral, in murine cells did not lead to trans-
formation (Collette et al., 2004; Hamad et al., 2002; Rangarajan
et al., 2004). However, active Ral proteins enhance transforma-
tion of NIH 3T3 cells expressing activated forms of Raf, and
dominant-negative Ral mutants can suppress their Ras-induced
transformation (Urano et al., 1996; White et al., 1996). Impor-
tantly, recent studies on conditional RalA and RalB knockout
mice have clearly demonstrated the importance of both Ral
GTPases for K-Ras-driven tumorigenesis in murine cells (Pe-
schard et al., 2012). By investigating kB-Ras-deficient and Ral-
GAPb knockdown murine fibroblasts as well as human cancer
cell lines, we confirm the importance of the kB-Ras/Ral-GAP/
Ral-signaling node for AIP in both mouse and human systems.
It is likely that the reported differences in the effects of Ral on
transformation of human versus mouse cells are due to the
different cell systems and immortalization methods used or
might be explainable by the fact that GTP-locked Ral mutants
cannot mimic all facets of chronic Ral activation.
Deficiency of kB-Ras leads to upregulation of both RalA- and
RalB-GTP levels. Knockdown studies in cancer cell lines had
originally suggested distinct functions of the two Ral GTPases
in tumor growth, with RalA promoting proliferation and RalB
enhancing cell survival. In our kB-Ras-deficient cells, the main
effect of increased Ral activity seems to be on proliferation,
which is in line with the recently published effects of RalA/RalB
knockout on K-Ras-driven tumorigenesis in vivo (Peschard
et al., 2012). We also investigated some of the described RalB-
specific functions. We find expression of the IRF3 target genes
IFIT1/ISG56 and IFNb increased in kB-Ras2-deficient macro-
phages in response to poly(I:C) stimulation. This may suggest
that, during a viral infection, both deregulated NF-kB and Ral
signaling would contribute to an increased immune response
in the case of kB-Ras deficiency. Furthermore, RalB has been
shown to upregulate autophagy, and congruently, we found
autophagy to be enhanced in kB-Ras DKO MEFs. Interestingly,
autophagy has been demonstrated to support tumorigenesis
as it can ensure cell survival by providing cellular energy during
starvation periods.(E) The ability of SV40/RasG12V-transformed DKOMEFs, stably expressingGFP,
to grow under anchorage-independent conditions was tested in Matrigel colony
(F) SV40/RasG12V-transformed DKO MEFs, stably expressing GFP, the Ral sup
jected in the flanks of scid-beige mice. Tumor volume (mm3) ± SEM is given (n =
(G and H) SV40/RasG12V-transformedWT and DKOMEFs or sh control and sh Ra
beige mice. After resection, mRNA levels for the indicated Ral- or NF-kB-depend
levels. Data are represented as mean ± SD (n = 5).
See also Figure S6.
Cell ReWe, and a number of independent groups, observed that kB-
Ras levels are reduced in tumors (Finak et al., 2008, Karnoub
et al., 2007, Garber et al., 2001, Murat et al., 2008, Sun et al.,
2006, Gerashchenko et al., 2010, Jou et al., 2010, Kim et al.,
2010). One study reported a correlation between kB-Ras protein
level and clinical outcome of glioma patients (Lin et al., 2012).
The mechanism responsible for the reduction in kB-Ras levels
remains to be determined. As the reduction is observed at the
mRNA level, the most likely explanations are either downregula-
tion of kB-Ras transcription or a posttranscriptional mechanism
that leads to enhanced degradation of the kB-Ras mRNA. The
kB-Ras1 and kB-Ras2 genes in humans are located on chromo-
somes 3 and 17, respectively, and analysis of their unique pro-
moter sequences failed to reveal an obvious pathway that would
explain decreased expression of both kB-Ras isoforms in
tumors. We are thus actively studying whether kB-Ras downre-
gulation occurs through transcriptional regulation or through ef-
fects on mRNA stability. Interestingly, we found that kB-Ras
levels are preferentially reduced in mutant K-Ras-expressing hu-
man lung cancer cell lines, suggesting that in these cells, which
critically depend on Ras and Ral activity for survival, a reduction
of kB-Ras levels might be advantageous for tumor growth as it
further boosts Ral activity.
In summary, we have identified kB-Ras proteins as regulators
of both NF-kB and Ral pathways. Suppression of both of these
pathways contributes to the ability of kB-Ras proteins to sup-
press Ras-driven tumorigenesis in vivo. Our studies place kB-
Ras proteins at the interface of cancer and inflammation and
raise the possibility that modulating kB-Ras function could
help counteract the proliferative and survival processes, as
well as the tumor-promoting inflammatory processes, that char-
acterize mutant Ras-driven tumorigenesis (Figure 7E).
EXPERIMENTAL PROCEDURES
Approval
All animal experiments were approved by the Columbia University Institutional
Animal Care and Use Committee and were conducted in an Association-for-
Assessment-and-Accreditation-of-Laboratory-Animal-Care-accredited
facility.
Cell Culture and Transfection
MEFs were generated from embryonic day 12.5 (E12.5) embryos. MEFs were
either immortalized following a standard 3T3 procedure (Todaro and Green,
1963) or through transfection with SV40 large T antigen. Immortalized MEF
lines, HEK293, and HEK293FT cell lines were cultured in Dulbecco’s modi-
fied Eagle’s medium (DMEM) containing 5% fetal bovine serum (FBS). Raw
cells were cultured in RPMI medium containing 10% FBS. For coimmunopre-
cipitation experiments, HEK293 cells were transfected using Lipofect-
amine2000 transfection reagent (Invitrogen) and lysed 24 hr after transfec-
tion. For retrovirus production, 3 3 106 HEK293FT cells were seeded per
10 cm dish and transfected using Fugene 6 (Roche). Virus was harvestedthe Ral superrepressor RBP1-RBD, or the IkB superrepressor (NF-kB inhibition)
formation assays. Data are represented as mean ± SD (Student’s t test; n = 3).
errepressor RBP1-RBD, or the IkB superrepressor (NF-kB inhibition) were in-
7).
l-GAPb-expressingMEFs were subcutaneously injected into the flanks of scid-
ent genes were analyzed by quantitative PCR and normalized to actin mRNA
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Figure 7. kB-Ras Levels Are Decreased in
Human Tumors and Affect the Tumorigenic
Capacity of Cells Derived from These Tu-
mors
(A) Changes in expression levels of kB-Ras1 and
kB-Ras2 mRNA between pancreatic adenocarci-
noma samples and matched healthy pancreatic
tissue from 15 patients was analyzed by quanti-
tative PCR and normalized to GAPDH mRNA
levels. Statistical significance was evaluated by
Wilcoxon rank test (kB-Ras1: p = 0.0038; kB-
Ras2: p = 0.023).
(B) The expression level of kB-Ras proteins was
analyzed in four wild-type Ras-expressing and five
mutant K-Ras-expressing cell lines by immuno-
blotting.
(C and D) The ability of NCI-23 (C) or NCI-1792
(D) human lung cancer cell lines stably trans-
duced with GFP or kB-Ras2 to grow under
anchorage-independent conditions was tested
in Matrigel colony formation assays. Data
are represented as mean ± SD (Student’s t test;
n = 3).
(E) kB-Ras proteins regulate both NF-kB-
dependent inflammation and Ral-dependent
proliferation. kB-Ras proteins negatively regulate
certain NF-kB target genes such as TNF-a
through their specific effect on the NF-kB inhib-
itor protein IkBb. As a consequence, genetic
ablation of kB-Ras leads to enhanced production
of proinflammatory cytokines and deregulated
inflammation. In addition, kB-Ras proteins are
required to maintain Ral-GAP activity in cells.
Absence of kB-Ras proteins consequently
results in upregulated Ral-GTP levels and
enhanced AIP. Both deregulation of inflammation
and proliferation contribute to the progression of
tumorigenesis.
See also Figure S7.48 hr after transfection and used to infect MEFs that had been seeded the
previous day at 1 3 105 cells per 10 cm dish. Antibiotic selection (puromycin
15 mg/ml and Zeocin 0.3 mg/ml) was started 48 hr after infection to achieve
stable expression.
Immunoprecipitation, Immunoblotting, and Gel Filtration
For all coimmunoprecipitations, cells were lysed in Co-IP buffer. Protein com-
plexes were precipitated with the respective antibodies for 2 hr to overnight at
4C. Precipitates were washed three times and then subjected to SDS-PAGE.
Proteins were transferred onto polyvinylidene fluoride (PVDF) membranes.
Membranes were blocked using 5% dry milk powder/Tris-buffered saline
(TBS)-T or 3% BSA/TBS-T and incubated with primary antibody overnight.
For gel filtration, cells were lysed in Co-IP buffer without glycerol. Lysates1804 Cell Reports 8, 1793–1807, September 25, 2014 ª2014 The Authorswere fractionated (0.5 ml fraction size) on Super-
ose 6 or Superdex 200 columns, and every second
fraction was analyzed by immunoblotting.
Analysis of Ral-GTP Levels
SV40-immortalized MEFs were seeded at 1 3 106
cells per 10 cm culture dish and starting on the
next day starved (DMEM without serum) for
24 hr. MEFs were then stimulated with EGF
(50 ng/ml) and lysed in Ral lysis buffer (50 mM
Tris [pH 7.5], 100 mM NaCl, 4 mM MgCl2, 2 mMEGTA, and 1% Triton X-100). GTP-bound RalA was precipitated from the
lysate with 20 mg GST-Sec5 bound to glutathione sepharose for 20 min. Pre-
cipitates were washed with Ral lysis buffer and analyzed by SDS-PAGE and
immunoblotting using RalA or RalB antibodies.
Tumorigenesis Assay
SV40-immortalized and H-Ras-G12V-transformed MEFs at a density of 2 3
107 cells/ml in cold PBS were mixed with Matrigel HC (BD Biosciences) at a
1:1 ratio. One million cells (100 ml volume) were injected subcutaneously into
both flanks of scid-beige mice (C.B-17; Taconic). Tumor volumes were deter-
mined every 2 to 3 days using a caliper and calculated as 1/23 length23width
in mm3. At the end of the study, tumors were resected, weighed, and snap
frozen for RNA preparation.
BrDU, Colony Formation, and Foci Formation Assays
Proliferation of fibroblasts was measured using a bromodeoxyuridine (BrDU)
cell proliferation assay kit (Calbiochem) according to manufacturer’s protocol.
For colony formation assays, 3,000 SV40-immortalizedMEFswere suspended
in 1.5 ml 1:1 Matrigel LC (BD Biosciences)/DMEM and seeded on 3 cm dishes
coated with 1.5 ml of 1% soft agar/DMEM. After solidification, the Matrigel
layer was overlaid with 0.5 ml growth medium, which was replenished once
a week. After 14 days, pictures were taken using a Zeiss Imager M2 micro-
scope with motorized stage, and colonies larger than 50 cells were scored us-
ing ImageJ software.
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